Anti-Ro52 antibodies in clinical practice: A single-centre experience.
Si WuXiaojun TangLiping WuLiangjing LuXuebing FengPublished in: International journal of clinical practice (2020)
Our study shows that anti-Ro52 could occur in various clinical conditions. These antibodies may appear in the early stage of CTD with the lung an important target organ, thus their presence warrants long-term follow-up.